A Multi-Center, Prospective, Randomized Trial Comparing the Effectiveness of Aurix Therapy to Usual and Customary Care in Venous Leg Ulcers
Description:
Recurrence of ulcers in the leg is common; two-thirds of patients are likely to experience
recurring ulcers after the first ulcer. While treatment of the underlying venous disease,
depending on the mode of treatment, can lower the recurrence rate in many patients, it does
not affect recurrence. Aurix is a platelet-rich plasma (PRP) gel used in the treatment of
non-healing chronic wounds. The aim of this trial is to demonstrate the effectiveness,
measured as complete wound healing, in a prospective, randomized trial in which venous leg
ulcers will be treated using Aurix and standard of care and compared 1:1 to patients
receiving undefined Usual and Customary Care (UCC).
Condition:
Venous Leg Ulcers
Treatment:
Aurix
Start Date:
February 2015
Sponsor:
Nuo Therapeutics
For More Information:
https://clinicaltrials.gov/show/NCT02352454